![Measures of Clinical Severity, Quality of Life, and Psychological Distress in Patients with Psoriasis: A Cluster Analysis - ScienceDirect Measures of Clinical Severity, Quality of Life, and Psychological Distress in Patients with Psoriasis: A Cluster Analysis - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0022202X15307466-gr1.gif)
Measures of Clinical Severity, Quality of Life, and Psychological Distress in Patients with Psoriasis: A Cluster Analysis - ScienceDirect
![Living with Psoriasis: Prevalence of Shame, Anger, Worry, and Problems in Daily Activities and Social Life | HTML | Acta Dermato-Venereologica Living with Psoriasis: Prevalence of Shame, Anger, Worry, and Problems in Daily Activities and Social Life | HTML | Acta Dermato-Venereologica](https://www.medicaljournals.se/acta/content_files/files/web/3607-web-images/3607fig1_opt.jpeg)
Living with Psoriasis: Prevalence of Shame, Anger, Worry, and Problems in Daily Activities and Social Life | HTML | Acta Dermato-Venereologica
![Inhibition of type 1 immunity with tofacitinib is associated with marked improvement in longstanding sarcoidosis | Nature Communications Inhibition of type 1 immunity with tofacitinib is associated with marked improvement in longstanding sarcoidosis | Nature Communications](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41467-022-30615-x/MediaObjects/41467_2022_30615_Fig1_HTML.png)